McMaster University

McMaster University

Mark Levine

[BACK]
Photo Biography, contacts and additional information
Photo of Mark Levine

MD. (McGill), M.Sc. (McMaster), FRCPC, FASCO

Professor and Chair
Department of Oncology
McMaster University


Scientific Director, Escarpment Cancer Research Institute
Director, Ontario Clinical Oncology Group (OCOG)
Buffett-Taylor Chair in Breast Cancer Research

 

Contacts

P: 905-527-4322 Ext. 42176
F: 905-389-9288
E: mlevine@mcmaster.ca

Administration
Lori Dale
P: 905-527-4322 Ext. 42176
F: 905-389-9288
E: dalel@mcmaster.ca

Clinical 

P: 905-387-9711, Ext. 63123
F: 905-575-6326

711 Concession Street
60 (G) Wing, 1st Floor, Room 104
Hamilton Ontario L8V 1C3

 

Enter email below for mentorship availability checker, or leave empty to disable:

Academic Interests

Dr. Levine's areas of interest include clinical trials in breast cancer and venous thromboembolism.

Selected Publications

  • Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M, Geerts W, Kassis J, Desjardins L, Cusson J, Cruickshank M, Powers P, Brien W, Haley S and Willan A. "A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis". New England Journal of Medicine 334:677-681, 1996.
  • Levine MN, Bramwell VH, Pritchard KI, Norris BD, Shepherd LE, Abu­-Zahra H, Findlay B, Warr D, Bowman D, Myles J, Arnold A, Vandenberg T, MacKenzie R, Robert J, Ottaway J, Burnell M, Williams CK, Tu D for the National Cancer Institute of Canada Clinical Trials Group. "Randomized trial of intensive cyclophosphamide, epirubicin and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate and fluorouracil in premenopausal women with node-positive breast cancer".  Journal of Clinical Oncology 16:2651-2658, 1998.
  • Lee AYY, Levine MN, Baker RI, Bowden C, Kakkar AJ, Prins M, Rickles FR, Julian JA,  Haley S, Kovacs MJ, and Gent M, for the Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT)Investigators. "Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer".  New England Journal of Medicine 349:146-153, 2003.

Search for publications for Dr. Levine on PubMed

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0